Orthofix Medical (OFIX) Competitors $11.12 +0.07 (+0.59%) As of 01:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OFIX vs. ATEC, ATRC, IART, SRDX, ANGO, ARAY, RMTI, RSLS, ABT, and ISRGShould you be buying Orthofix Medical stock or one of its competitors? The main competitors of Orthofix Medical include Alphatec (ATEC), AtriCure (ATRC), Integra LifeSciences (IART), Surmodics (SRDX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "health care equipment" industry. Orthofix Medical vs. Its Competitors Alphatec AtriCure Integra LifeSciences Surmodics AngioDynamics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Alphatec (NASDAQ:ATEC) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations. Is ATEC or OFIX more profitable? Orthofix Medical has a net margin of -17.78% compared to Alphatec's net margin of -25.77%. Orthofix Medical's return on equity of -28.15% beat Alphatec's return on equity.Company Net Margins Return on Equity Return on Assets Alphatec-25.77% -1,657.19% -21.53% Orthofix Medical -17.78%-28.15%-16.51% Which has higher valuation & earnings, ATEC or OFIX? Orthofix Medical has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlphatec$611.56M2.63-$162.12M-$1.15-9.55Orthofix Medical$799.49M0.55-$126M-$3.69-3.01 Do institutionals and insiders have more ownership in ATEC or OFIX? 66.4% of Alphatec shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 20.9% of Alphatec shares are owned by company insiders. Comparatively, 1.3% of Orthofix Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media refer more to ATEC or OFIX? In the previous week, Orthofix Medical had 1 more articles in the media than Alphatec. MarketBeat recorded 5 mentions for Orthofix Medical and 4 mentions for Alphatec. Alphatec's average media sentiment score of 0.91 beat Orthofix Medical's score of 0.82 indicating that Alphatec is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alphatec 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Orthofix Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer ATEC or OFIX? Alphatec presently has a consensus price target of $17.89, suggesting a potential upside of 62.85%. Orthofix Medical has a consensus price target of $21.50, suggesting a potential upside of 93.26%. Given Orthofix Medical's stronger consensus rating and higher possible upside, analysts plainly believe Orthofix Medical is more favorable than Alphatec.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alphatec 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89Orthofix Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more risk & volatility, ATEC or OFIX? Alphatec has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. SummaryOrthofix Medical beats Alphatec on 11 of the 17 factors compared between the two stocks. Get Orthofix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OFIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OFIX vs. The Competition Export to ExcelMetricOrthofix MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$433.34M$6.92B$5.54B$8.95BDividend YieldN/A1.23%5.38%4.08%P/E Ratio-3.0126.6327.4020.04Price / Sales0.5599.70419.46118.60Price / CashN/A20.9736.6357.47Price / Book0.854.748.085.67Net Income-$126M$173.18M$3.16B$248.47M7 Day Performance0.77%1.52%2.12%2.90%1 Month Performance0.86%0.14%4.43%5.75%1 Year Performance-17.71%28.37%35.62%21.36% Orthofix Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OFIXOrthofix Medical3.2721 of 5 stars$11.13+0.6%$21.50+93.3%-16.8%$433.34M$799.49M-3.011,616Gap UpATECAlphatec4.3372 of 5 stars$10.86-0.7%$17.89+64.7%+10.7%$1.60B$611.56M-9.44700ATRCAtriCure3.3268 of 5 stars$31.90+1.6%$50.67+58.8%+40.2%$1.55B$465.31M-39.381,300News CoveragePositive NewsIARTIntegra LifeSciences4.0762 of 5 stars$11.62+0.2%$18.63+60.3%-53.7%$901.46M$1.61B-30.584,396SRDXSurmodics4.2325 of 5 stars$29.00flat$43.00+48.3%-30.9%$414.68M$126.08M-20.86450News CoverageAnalyst RevisionANGOAngioDynamics3.9884 of 5 stars$9.99-0.3%$14.00+40.1%+65.9%$406.88M$303.91M-9.89760Positive NewsARAYAccuray3.649 of 5 stars$1.25+2.5%N/A-20.6%$125.68M$446.55M-25.001,040Positive NewsRMTIRockwell Medical4.0876 of 5 stars$0.87-2.2%$4.00+359.5%-51.6%$30.42M$101.49M-43.53300RSLSReShape Lifesciences0.1683 of 5 stars$2.56+0.4%N/A-99.1%$6.08M$8.01M-0.0150ABTAbbott Laboratories4.8987 of 5 stars$133.26+0.2%$142.61+7.0%+29.9%$231.38B$41.95B17.28114,000Trending NewsISRGIntuitive Surgical4.3345 of 5 stars$515.09+1.1%$588.95+14.3%+23.2%$182.56B$8.35B75.5315,638Positive News Related Companies and Tools Related Companies Alphatec Competitors AtriCure Competitors Integra LifeSciences Competitors Surmodics Competitors AngioDynamics Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OFIX) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orthofix Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orthofix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
